Severe Insulin Resistance with Diabetic Ketoacidosis After Brentuximab Treatment

ABSTRACT: Objective: To increase awareness of unusual inflammatory and other responses including severe insulin resistance (IR) associated with the use of targeted immunotherapies such as brentuximab. Methods: We report the case of a man without any previous diagnosis of diabetes who developed diab...

Full description

Bibliographic Details
Main Authors: Janet M. Chiang, MD, Andrew R. Lai, MD, MPH, Mark Anderson, MD, PhD, Robert J. Rushakoff, MD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520300559